Latest Content

Weekly smartphone check-ins that alerted the care team when symptoms worsened and improved physical functioning at six months.

Divesiran met the primary end point of the phase 2 SANRECO trial, with 88% of patients avoiding phlebotomy and keeping hematocrit below 45%, according to new trial results.

Doctors say patients with cancer face distinct risks during the cyclosporiasis outbreak that spans 45 states.

After moving two hours away, a survivor weighs staying with the cancer center that knows her history against finding an oncologist close to home.

Sanita Burgic, of Washington University Siteman Cancer Center, combines clinical excellence and deep empathy to support cancer patients and elevate her entire oncology team.

Dr. Priscilla Merriam discusses how sarcomas can be mistaken for benign growths like lipomas and fibroids, and why asking about a biopsy can matter before surgery.

Lung cancer advocate Katie shares how losing her father to the disease and her own cancer journey inspire her work with LiveLung today.

Multiple myeloma and breast cancer survivor Valerie Traynham shares why survivorship begins at diagnosis and offers hope, resilience and life after cancer insights.

An oncologist explains why the choice between removing one lobe or the whole thyroid should be a conversation, not a surprise.

Dr. Robert S. Alter discusses what to ask before thyroid surgery, why "active surveillance" isn't passive and how targeted therapy is changing outcomes.

At least half of patients get nervous before a follow-up scan. Dr. Geoffrey Pelz explains why that is common, what he wants patients to hear at the first visit and how much lung cancer treatment has shifted in 15 years.

FDA approves Tudriqev plus Opdivo for adults with advanced melanoma that progressed after PD-1 immunotherapy, expanding treatment options.

After my insurance denied the cancer treatment that worked, every appeal failed. Here's how resilience and advocacy helped me move forward.